Friday, Feb 14, 2025 · SEC filings
What the smart money revealed on Feb 14
952 insider filings came in. We hid 78 planned (10b5-1) sellers and 722 people whose filings were routine, like grants and tax withholding.
3 insiders at CompoSecure (GPGI) bought $16.6M of stock
Roles: Director. Several insiders buying in the same few days is rare.
Amentum (AMTM) Executive Chair Steven Demetriou bought $2.08M
100,000 shares on the open market. Not a grant or an option exercise.
Amcor (AMCR) Director Arun Nayar bought $995K
100,000 shares on the open market. Not a grant or an option exercise.
Oracle (ORCL) Director Charles Moorman bought $948K
5,500 shares on the open market. Not a grant or an option exercise.
Pfizer (PFE) Director Ronald Blaylock bought $499K
19,457 shares on the open market. Not a grant or an option exercise.
Charles Schwab (SCHW) Co-Chairman Walter Bettinger sold $38.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 827,377 shares directly.
Johnson Controls International (JCI) Chairman and CEO George Oliver sold $29M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 2.41M shares directly.
Hamilton Lane (HLNE) Executive Co-Chairman Hartley Rogers sold $1.63M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 27 more real buys
Show 89 more real sales
13F season
Holdings as of Dec 31, 2024 are due Feb 14
81 funds have filed so far. 58 filed for the quarter before.
Biggest real insider buys, Feb 8–14
Open-market buys by officers and directors, filed in the 7 days up to Feb 14.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.